Bleomycin-induced flagellate hyperpigmentation

BMJ Case Rep. 2013 Jun 5:2013:bcr2013009745. doi: 10.1136/bcr-2013-009745.

Abstract

Bleomycin is a chemotherapeutic agent used in the treatment of different tumours. It has several side effects, including flagellate hyperpigmentation, which is a unique and a well-documented side effect of bleomycin therapy. We report a case of a 23-year-old woman with a personal history of ovarian dysgerminoma, who developed flagellate hyperpigmentation on trunk after bleomycin therapy.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antibiotics, Antineoplastic / adverse effects*
  • Bleomycin / adverse effects*
  • Combined Modality Therapy
  • Dysgerminoma / drug therapy*
  • Dysgerminoma / surgery
  • Female
  • Humans
  • Hyperpigmentation / chemically induced*
  • Ovarian Neoplasms / drug therapy*
  • Ovarian Neoplasms / surgery
  • Treatment Outcome
  • Young Adult

Substances

  • Antibiotics, Antineoplastic
  • Bleomycin